麻醉症,更新时间为2023年
L Barateau1, F Pizza2, S Chenini1
1Sleep-Wake Disorders Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU de Montpellier, Montpellier, France; National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, and Kleine-Levin Syndrome, Montpellier, France; Institute of Neurosciences of Montpellier, University of Montpellier, Inserm, Montpellier, France.
Revue neurologique
|August 27, 2023
概括
麻醉症类型1 (NT1) 是由素神经元损失引起的,通过脑脊液中素-1/素-A水平被诊断出来. 新的诊断标准和即将推出的素受体激动剂为麻醉症提供了更好的管理.
科学领域:
- 神经科学是一个神经科学.
- 睡眠医学 睡眠医学
- 内分泌学 在内分泌学.
背景情况:
- 麻醉症类型1 (NT1) 和2 (NT2) 是不同的睡眠障碍,最近的科学进展.
- NT1的发病包括失去生产素/白蛋白的下丘脑神经元,这对于唤醒调节至关重要.
- 素缺乏是NT1关键症状的基础:过度的白天嗜睡,触觉障碍,睡眠障碍,幻觉和.
研究的目的:
- 审查1型和2型麻醉症的诊断标准和生物标志物.
- 讨论催素-1/素-A在NT1诊断中的作用.
- 探索临床特征,诊断挑战和麻醉症的未来治疗策略.
主要方法:
- 对脑脊液 (CSF) 低克列-1/素-A水平作为NT1的诊断生物标志物的分析1.
- 对神经生理学测试 (多睡眠学,多重睡眠延迟测试) 和诊断麻醉症的临床标准的审查.
- 检查修订的睡眠障碍国际分类,第三版 (ICSD-3-TR) 诊断指南.
主要成果:
- 脑液中低克列-1/素-A是一种高度特异和敏感的生物标志物,用于诊断NT1.1.
- ICSD-3-TR更新了诊断标准,允许睡眠开始的REM周期 (SOREMPs) 在特定情况下取代日间测试.
- 触觉障碍症的诊断严重依赖于临床面试,为典型和非典型的攻击提出了特征.
结论:
- 素缺乏是NT1的确切原因,其中脑液中素-1/素-A作为关键的诊断标志物.
- 由于未知的病因和缺乏特定生物标志物,NT2诊断仍然具有挑战性.
- 症状治疗是当前的标准,但素受体激动剂有望为麻醉症带来革命性的治疗进展.
相关概念视频
Narcolepsy
137
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
137
Sleep-Wake Cycles
1.4K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.4K
REM Sleep Behavior Disorder
248
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
248
Management of Insomnia
278
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
278
Substance Use Disorders Affecting Sleep
196
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
196
Sedatives and Hypnotics Drugs: Miscellaneous Agents
200
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
200


